1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Meclizine |
| brand | String | Antivert (Rx), Bonine (OTC), Dramamine Less Drowsy (OTC) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antihistamines|First-generation antihistamine (piperazine)]] • [[:Category:Antiemetics|Antiemetic]] • [[:Category:Antivertigo medicines|Antivertigo medicine]] |
| mechanism | String | '"`UNIQ--vote-00000013-QINU`"' Anticholinergic burden (dry mouth, blurred vision, urinary retention, cognitive effects) is the principal adverse-event concern and the basis for Beers-list cautions in elderly patients'"`UNIQ--ref-00000014-QINU`"'. |
| uses | String | '"`UNIQ--vote-00000015-QINU`"', '"`UNIQ--vote-00000016-QINU`"', '"`UNIQ--vote-00000017-QINU`"' |
| starting_dose | String | Motion sickness: 25-50 mg PO 1 hour before travel, repeat every 24 hours as needed. Vertigo: 25-100 mg/day divided |
| preparations | String | Tablets 12.5, 25 mg; chewable tablets 25 mg |
| fda_max | String | 100 mg/day (vertigo) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | ~1 hour |
| duration | String | 12-24 hours (long for an antihistamine) |
| halflife | String | ~6 hours'"`UNIQ--ref-00000018-QINU`"' |
| bioavailability | String | ~25% (oral)'"`UNIQ--ref-00000019-QINU`"' |
| pregnancy | String | Older agent with substantial use experience; observational signals reassuring for first-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Over-the-counter|OTC]] as Bonine and Dramamine Less Drowsy; [[USLegal:Prescription only|Rx-only]] as Antivert |
